Article content

TORONTO — Licensed marijuana producer Aphria Inc. has struck an $826-million deal to buy Nuuvera Inc. to fuel its international expansion efforts, marking the latest move by a Canadian cannabis company to extend its global reach while U.S. competition is kept at bay.

The cash-and-stock deal to buy the Toronto-based medical cannabis firm builds on a partnership between the companies as it combines Aphria’s production with Nuuvera’s expertise in cannabis processing and extraction.

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or Licensed marijuana producer Aphria Inc. signs deal to buy Nuuvera Inc. Back to video

Nuuvera, which is in the final stages under Health Canada’s process to become a licensed marijuana producer, has business relationships in the Middle East, Africa and Europe, including a license to import medical cannabis to Italy for sales to domestic pharmacies.

“In all, this positions us to grow internationally and realize the potential of these emerging cannabis markets,” Aphria chief executive Vic Neufeld told analysts on a conference call Monday.